PATHWAY MAPPING
WP1: Mapping current diagnostic pathways for COPD in the UK
COPD diagnostic pathways, and particularly the provision of spirometry services, have changed considerably in the last 5 years, and are known to vary widely across the UK. We are looking to gain an up-to-date picture of the different ways COPD is diagnosed in adults in community/primary care and to identify barriers and facilitators in diagnostic service provision for COPD.
To achieve this, we will take a mixed methods approach to include the perspectives and experiences of healthcare professionals/professional stakeholders involved in COPD diagnosis.
This work package includes three components:
- A survey of Integrated Care Systems/Boards (ICS/ICBs) in England to update and gather more information about spirometry provision nationally, in collaboration with Asthma+Lung UK's ICS Respiratory Review.
- An in-depth survey to capture the views and experiences of healthcare professionals and stakeholders involved in COPD diagnosis in UK primary/community care. The survey aims to build a picture of what current diagnostics pathways are and identify barriers and facilitators in diagnostic service provision for COPD, as well as inform the development and implementation of new diagnostic technologies for COPD.
- Qualitative interviews with survey respondents and others will contextualise and deepen our understanding about COPD diagnostic pathways, current challenges and how novel diagnostic technologies could help and how they could be implemented. This will guide the development and implementation of N-Tidal as well as feed into the other work packages.
This survey is currently live and looking for respondents
You can take part if you are a clinician or professional involved in COPD diagnosis (including service delivery/planning roles and/or secondary/specialist care).
It will only take 15-30 minutes to complete and completed entrants will be eligible to enter a prize draw for the chance to win one of four £50 gift vouchers.
If you have any questions, please contact the lead researcher Dr Caity Roleston (caity.roleston@phc.ox.ac.uk).